Drug utilization study in the otorhinolaryngology department in a tertiary care hospital

S. A. Sridevi, T. Janagan, P. Rathnasamy, R. Rajarajeswari

Abstract


Background: Drug utilization is defined by the World Health Organization (WHO) as the marketing, distribution, prescription, and use of drugs in society, with special emphasis on the resulting medical, social, and economic consequences. The aim of this study was to evaluate the pattern of prescription and then drug utilization in outpatient (OPD) of the Department of Otolaryngology in a tertiary care teaching hospital.

Methods: This was a retrospective study conducted at the A.C.S. medical college and hospital, Chennai for a period of 7 months. All the patients who attended the Ear Nose and Throat (ENT) OPD were included. The total number who attended the OPD was 10,249 which include 6,956 new cases and 3313 old cases.

Results: The antibacterials commonly used were β Lactams (56%), macrolides (14%), fluoroquinolones (12%), aminoglycosides (8%). Among the penicillin group, the commonest drug prescribed was a combination of amoxicillin and clavulanic acid (27%), in cephalosporins was cefixime + clavulanic acid (19%). Aminoglycosides include gentamycin in refractory cases. Fluoroquinolones include ciprofloxacin and levofloxacin. Others Drugs like antihistamines and mucolytics were prescribed in 27%, anti- ulcer drugs in 36% cases, analgesics in 33% cases and herbal medicines in 4%. The average number of drugs used in each prescription was 3.20. All the drugs were prescribed with brand names. The average cost per prescription per day for OPD patients is 37 Rupees.

Conclusions: β Lactams were commonly used antibacterials in the otorhinolaryngology department.


Keywords


Drug utilization, Prescription pattern, Pharmacoeconomics, Otorhinolaryngology department, Antibacterial agents

Full Text:

PDF

References


Sjöqvist F, Birkett D. WHO booklet introduction to drug utilization research, chapter 10 drug utilization; 2003:76-84.

Serradell J, Bjornson DC, Hartzema AG. Drug Utilization Study Methodologies: National and International Perspectives. Drug Intell Clin Pharm 1987;21:994-1001.

Bégaud B. Dictionary of Pharmaco epidemiology. Chichester: John Wiley & Sons, Ltd; 2000.

Hartzema AG, Porta M, Tilson HH. Pharmacoepidemiology: An Introduction, 3rd Edition. 1998. Cincinnati: Harvey Whitney Books.

Erwin WG. The Definition of Drug Utilization Review: Statement of Issues. Clin Pharmacol Ther 1991;50(5 Pt 2):596-9.

Truter I. A review of drug utilization studies and methodologies. Jordan J Pharmaceutical Sci 2008;1:91-104.

Dhingra PL. Diseases of ear, nose and throat. 3 rd Ed. New Delhi: Mosby, Saunders, Elsevier; 2004:62-117.

Yadav P, Kanase V, Lacchiramka P, Jain S. Drug utilization trends in ENT out patient department in a teaching hospital. Int J Pharma Bio Sci 2010;1:153-9.

Anon JB. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Pediatr Drugs 2003;5:25-33.

Khan FA, et al. Patterns of prescription of antimicrobial agents in the Department of Otorhinolaryngology in a tertiary care teaching hospital. African J Pharmacy Pharmacol 2011;5:1732-8.

Atanasova I, Terziivanov D. Investigations on antibiotics in a hospital for 1 year period. Int J Clin Pharmacol Ther 1995;33:32-3.